Journal article
Procalcitonin is not a reliable biomarker of bacterial coinfection in people with coronavirus disease 2019 undergoing microbiological investigation at the time of hospital admission
- Abstract:
- Admission procalcitonin measurements and microbiology results were available for 1040 hospitalized adults with coronavirus disease 2019 (from 48 902 included in the International Severe Acute Respiratory and Emerging Infections Consortium World Health Organization Clinical Characterisation Protocol UK study). Although procalcitonin was higher in bacterial coinfection, this was neither clinically significant (median [IQR], 0.33 [0.11–1.70] ng/mL vs 0.24 [0.10–0.90] ng/mL) nor diagnostically useful (area under the receiver operating characteristic curve, 0.56 [95% confidence interval, .51–.60]).
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 494.7KB, Terms of use)
-
- Publisher copy:
- 10.1093/ofid/ofac179
Authors
- Publisher:
- Oxford University Press
- Journal:
- Open Forum Infectious Diseases More from this journal
- Volume:
- 9
- Issue:
- 5
- Article number:
- ofac179
- Publication date:
- 2022-05-01
- Acceptance date:
- 2022-04-01
- DOI:
- EISSN:
-
2328-8957
- Language:
-
English
- Keywords:
- Pubs id:
-
1268802
- Local pid:
-
pubs:1268802
- Deposit date:
-
2022-07-25
Terms of use
- Copyright holder:
- Relph et al.
- Copyright date:
- 2022
- Rights statement:
- ©2022 The Author(s). Published by Oxford University Press on behalf of Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record